TGM2-mediated histone serotonylation promotes HCC progression via MYC signaling pathway
Mechanistic study of TGM2 inhibition with GK921 exposes drug targetable vulnerabilities in HCC. MHCC-97H cells were exposed to DMSO and/or GK921. Following 24 hours exposure, RNA was extracted from these cells and then subjected to RNA sequence analysis.